Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Tunable, biodegradable gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging.

Cheheltani R, Ezzibdeh RM, Chhour P, Pulaparthi K, Kim J, Jurcova M, Hsu JC, Blundell C, Litt HI, Ferrari VA, Allcock HR, Sehgal CM, Cormode DP.

Biomaterials. 2016 Sep;102:87-97. doi: 10.1016/j.biomaterials.2016.06.015. Epub 2016 Jun 7.

PMID:
27322961
2.

Imaging of Liver Tumors Using Surface-Enhanced Raman Scattering Nanoparticles.

Andreou C, Neuschmelting V, Tschaharganeh DF, Huang CH, Oseledchyk A, Iacono P, Karabeber H, Colen RR, Mannelli L, Lowe SW, Kircher MF.

ACS Nano. 2016 May 24;10(5):5015-26. doi: 10.1021/acsnano.5b07200. Epub 2016 May 10.

3.

Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.

Laeseke PF, Chen R, Jeffrey RB, Brentnall TA, Willmann JK.

Radiology. 2015 Dec;277(3):644-61. doi: 10.1148/radiol.2015141020.

PMID:
26599925
4.

In vivo small animal micro-CT using nanoparticle contrast agents.

Ashton JR, West JL, Badea CT.

Front Pharmacol. 2015 Nov 4;6:256. doi: 10.3389/fphar.2015.00256. eCollection 2015. Review.

5.

Molecular Imaging of Tumors Using a Quantitative T 1 Mapping Technique via Magnetic Resonance Imaging.

Herrmann K, Johansen ML, Craig SE, Vincent J, Howell M, Gao Y, Lu L, Erokwu B, Agnes RS, Lu ZR, Pokorski JK, Basilion J, Gulani V, Griswold M, Flask C, Brady-Kalnay SM.

Diagnostics (Basel). 2015;5(3):318-32. doi: 10.3390/diagnostics5030318.

6.

Tumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide Dendrimer (ACPPD-Gd), a T1 Magnetic Resonance (MR) Molecular Imaging Agent.

Malone CD, Olson ES, Mattrey RF, Jiang T, Tsien RY, Nguyen QT.

PLoS One. 2015 Sep 3;10(9):e0137104. doi: 10.1371/journal.pone.0137104. eCollection 2015.

7.

Synthesis and characterisation of ultrasound imageable heat-sensitive liposomes for HIFU therapy.

Maples D, McLean K, Sahoo K, Newhardt R, Venkatesan P, Wood B, Ranjan A.

Int J Hyperthermia. 2015;31(6):674-85. doi: 10.3109/02656736.2015.1057622. Epub 2015 Jul 17.

PMID:
26185910
8.

Surface-Enhanced Raman Spectroscopy: A New Modality for Cancer Imaging.

Andreou C, Kishore SA, Kircher MF.

J Nucl Med. 2015 Sep;56(9):1295-9. doi: 10.2967/jnumed.115.158196. Epub 2015 Jul 16. Review.

PMID:
26182971
9.

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

Li Z, Sun J, Yang X.

Biomed Res Int. 2015;2015:595467. doi: 10.1155/2015/595467. Epub 2015 Mar 22. Review.

10.

Ultrasound molecular imaging: Moving toward clinical translation.

Abou-Elkacem L, Bachawal SV, Willmann JK.

Eur J Radiol. 2015 Sep;84(9):1685-93. doi: 10.1016/j.ejrad.2015.03.016. Epub 2015 Mar 21. Review.

PMID:
25851932
11.

Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging.

Harmsen S, Huang R, Wall MA, Karabeber H, Samii JM, Spaliviero M, White JR, Monette S, O'Connor R, Pitter KL, Sastra SA, Saborowski M, Holland EC, Singer S, Olive KP, Lowe SW, Blasberg RG, Kircher MF.

Sci Transl Med. 2015 Jan 21;7(271):271ra7. doi: 10.1126/scitranslmed.3010633.

12.

Dynamic magnetic fields remote-control apoptosis via nanoparticle rotation.

Zhang E, Kircher MF, Koch M, Eliasson L, Goldberg SN, Renström E.

ACS Nano. 2014 Apr 22;8(4):3192-201. doi: 10.1021/nn406302j. Epub 2014 Mar 20.

13.

Multicolor computed tomographic molecular imaging with noncrystalline high-metal-density nanobeacons.

Pan D, Schirra CO, Wickline SA, Lanza GM.

Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):13-25. doi: 10.1002/cmmi.1571. Review.

14.

Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications.

Tzu-Yin W, Wilson KE, Machtaler S, Willmann JK.

Curr Pharm Biotechnol. 2013;14(8):743-52. Review.

15.

Molecular imaging for cancer diagnosis and surgery.

Hussain T, Nguyen QT.

Adv Drug Deliv Rev. 2014 Feb;66:90-100. doi: 10.1016/j.addr.2013.09.007. Epub 2013 Sep 22. Review.

16.
17.

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

Burden-Gulley SM, Zhou Z, Craig SE, Lu ZR, Brady-Kalnay SM.

Transl Oncol. 2013 Jun 1;6(3):329-37. Print 2013 Jun.

18.

Whole-body imaging of adoptively transferred T cells using magnetic resonance imaging, single photon emission computed tomography and positron emission tomography techniques, with a focus on regulatory T cells.

Leech JM, Sharif-Paghaleh E, Maher J, Livieratos L, Lechler RI, Mullen GE, Lombardi G, Smyth LA.

Clin Exp Immunol. 2013 May;172(2):169-77. doi: 10.1111/cei.12087.

19.

A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probes.

Liu Y, Yang Y, Zhang C.

Int J Nanomedicine. 2013;8:1083-93. doi: 10.2147/IJN.S39880. Epub 2013 Mar 14. Review.

20.

Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging.

Matsunaga TO, Sheeran PS, Luois S, Streeter JE, Mullin LB, Banerjee B, Dayton PA.

Theranostics. 2012;2(12):1185-98. doi: 10.7150/thno.4846. Epub 2012 Dec 23. Review.

Items per page

Supplemental Content

Write to the Help Desk